The high expression of immune-regulator CTLA4, PD1, and PD-L1 in TNBC generated from lymphocyte infiltration of the tumor, is probably associated with response to immune checkpoint inhibitors regardless the molecular subtype [11]. The gene discussed is CD274; the disease is neoplasm.